Protocol Ledger

NCT07015892 · Phase III · RECRUITING

Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial

Interventional Phase III clinical trial protocol NCT07015892 sponsored by Instituto de Investigación Biomédica de Salamanca in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-03-01 Enrollment: 300 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07015892
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)300 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07015892
Protocol FieldVerified Registry Value
NCT IdentifierNCT07015892
Consolidated Lead SponsorInstituto de Investigación Biomédica de Salamanca
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment300 participants (ESTIMATED)
Registered Start Date2026-03-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07015892
Hospital Research SiteLocationSite Profile
Hospital Universitario Virgen del RocioSeville, SpainOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI